Objective: Environmental and genetic factors influence thyrotoxicosis, but how population
Introduction
The incidence of thyrotoxicosis has previously been determined in Sweden and studies showed a variation between 25.8 and 43.0 cases per 100 000 per year (1) (2) (3) (4) . In other studies in Europe, outside Sweden, performed in Iceland, Denmark, and the UK the incidence varied between 9.7 and 56.5 per 100 000 and year (5) (6) (7) (8) (9) (10) . In a study in New Zealand, the incidence was 25.8 per 100 000 per year (11) . Factors such as type of area studied, time period, type of method, and types of thyrotoxicosis included may explain some of the variations. In addition, the inclusion of children or not may also affect the total incidence. However, it is well known that genetic, environmental, and endogenous factors influence development of thyrotoxic disease and factors like gender, age, smoking habits, family history, stress, and iodine status contribute to the type of thyroid illness (12) (13) (14) .
In an urban area (Malmö) in southern Sweden the incidence of thyrotoxicosis as well as Graves' disease increased between the time periods1970 -1974 and 1988-1990 (3) . Several factors like more sensitive diagnostic tools and smoking habits were suggested as explanations. Since 1990 Since , until 2003 , the population in Malmö increased from 232 000 to 267 000, concomitantly the proportion of inhabitants born outside Sweden increased more than the proportion of inhabitants born in Sweden. The aim in this prospective study was to further investigate if factors like geographic origin affect the incidence of thyrotoxicosis.
Material and methods

Patients
The study was approved by the ethical review board, Lund University, Malmö/Lund, Sweden, and informed consent was obtained before inclusion. All patients living in the town of Malmö, without a previous history of thyrotoxicosis, and newly diagnosed with overt thyrotoxicosis due to Graves' disease (GD), thyrotoxic multinodular goiter (TMNG), or solitary toxic adenoma (STA) during the years 1 January 2003-31 December 2005 were prospectively registered and included. Patients with thyroiditis or recurrence of thyrotoxicosis were not included. The diagnosis of thyrotoxicosis was based on clinical symptoms and signs, plasma concentrations of TSH !0.2 mIU/l, increased plasma levels of free T 4 and/or free tri-iodothyronine (T 3 ). The area of inclusion was Malmö, a seaport town in southern Sweden, with a mean population of 269 195 inhabitants during the time period [2003] [2004] [2005] . There is only one hospital in Malmö, the population is demographically well defined and the town is suitable for epidemiological studies. From the years 1990 to 2003, the population increased from 232 000 to 267 000 and the proportion of inhabitants born outside Sweden increased from 16% in 1990 to 25% in 2003. Demographic information of the population in Malmö was obtained from the database Official Statistics of Sweden. The following parameters were registered at diagnosis of thyrotoxicosis: age, gender, type of thyrotoxicosis (GD, TMNG, and STA), smoking habits (smokers, ex-smokers, and non-smokers), and geographic background (born in Sweden, born in Europe outside Sweden, and born outside Europe). The patients were classified as having GD on the basis of clinical signs, presence of TSH receptor antibodies (TRab), and/or a diffuse uptake on technetium scintigraphy. The diagnosis of TMNG and STA was based on clinical signs, the uptake on technetium scintigraphy and the absence of TRab. The majority of patients were included at their first visit to the department of Endocrinology. Patients were also included at the departments of Pediatrics or Oncology at Malmö University Hospital or after visiting a private practitioner. All general practitioners in Malmö received a letter where they were asked to inform us if they treated patients with thyrotoxicosis. We also checked registers of diagnosis at departments of Endocrinology, Pediatrics, Oncology, Surgery, and Internal Medicine at Malmö University hospital. Lund University hospital is situated close to Malmö and we also checked their diagnosis registers for the presence of patients with a home address in Malmö. We find the previous study 1988-1990 valid and comparable because the structure of the hospital and the uptake area were similar. In addition, one of the authors (B H) of this study was a co-author of the previous study.
Assays
Using the ELISA technique, plasma TSH (reference interval 0.4-3.5 mIU/l, sensitivity 0.001 mIU/l, CV 10%), free T 4 (reference interval 8-14 pmol/l, sensitivity 2 pmol/l, CV 10%), free T 3 (reference interval 3.5-5.4 pmol/l, sensitivity 2 pmol/l, CV 10%) were measured according to the manufacturers description (Beckman Coulter, Bromme, Sweden) in clinical routine at department of Clinical Chemistry at Malmö University hospital.
TRab was measured in a routine laboratory using a human radio receptor assay kit purchased from Brahms and following the instructions from the supplier (reference interval !1 IU/l, sensitivity 0.3 IU/l, CV 9.3-15.4%). For information of the assays used in the previous study, please see Berglund et al. (3) .
Statistical analysis
Episheet, written by Ken Rothman (http://members.aol. com/krothman/modepi.htm), was used to calculate incidence differences with 95% confidence interval, and to test incidence differences and homogeneity (15) .
Results
The incidence of thyrotoxicosis in Malmö has previously been registered retrospectively in the years [1988] [1989] [1990] . In this study, patients with thyrotoxicosis were prospectively registered during the years 2003-2005. The incidence of Graves' thyrotoxicosis (GD) increased by 33% as compared to the years 1988-1990 (Table 1) . This was in contrast to the incidence of TMNG and STA which decreased by 38 and 56% respectively ( Table 1) In GD, the age-specific incidence 2003-2005 showed a significantly changed distribution as compared with 1988-1990 with a distinct maximum in the age-group 50-59 years (confidence interval K29.9 to K0.5; Fig. 1A ). In the group with TMNG or STA the agespecific incidence was generally on a significantly lower level during the years 2003-2005 as compared with 1988-1990 except in patients older than 80 years (Fig. 1B) . The sex ratio of females and males in GD was 3.8 to 1 (Table 1) which is similar to 1988-1990 but in patients with TMNG and STA the proportion of males was increased (Table 1 ). There was an over-representation of smokers in GD as compared with TMNG and STA ( Table 2) . Between the years 1988-1990 and 2003-2005 the population in Malmö increased by 15% and the inhabitants born outside Sweden increased by 54%. During the same time period, the incidence of GD increased and the proportion of GD in immigrants was increased as compared with patients born in Sweden (Table 3 ). In the group with TMNG and STA, the proportion of patients born outside Sweden was decreased as compared with patients born in Sweden (Table 3) . This was not explained by a shift in the ratio women/men because the proportion was similar in immigrants and Swedes, but the age-structure shows that the proportion of inhabitants older than 70 years was increased in the latter group (Table 4) . How about smoking habits in immigrants and Swedes? The highest proportion of smokers was seen in patients born in Europe, outside Sweden, and the lowest proportion was seen in patients born outside Europe, which also showed the highest share of GD, therefore factors other than smoking may contribute to GD.
Age-specific incidence in women with Graves' was higher in patients born outside Sweden than in females born in Sweden in all age-groups up to 69 years but statistically not significantly different (Fig. 2) . The highest incidence was seen in the age-group 50-59 years both in women born in and outside Sweden which was statistically significant as compared with the age- Fig. 2 ). The greatest difference in age-specific incidence between the two groups was seen in the agegroups 20-29 and 70-79 years, but was found not significant ( Fig. 2) .
Discussion
The present report describes a change in the incidence of GD and TMNG where the proportion of GD has increased and TMNG has decreased in Malmö during the time periods 1988-1990 until 2003-2005 . In parallel, the share of immigrants in Malmö has increased more than the population in general and it is shown that the proportion of GD is higher and TMNG/STA is lower in the immigrant group. The age-specific incidence is the highest in the age-group 50-59 years. Stress is one factor with impact on the development of GD (14) . Therefore, one explanation could be that immigrants in general, may find it stressful to live in a new country. However, one would expect an overrepresentation of patients who have lived in Sweden for a short period of time but there was no simple correlation to the time lived in Sweden (data not shown).
Another factor that can affect the development of GD is a change in iodine status especially if the iodine intake is sharply increased, but a chronic iodine excess has been suggested not to increase the incidence of GD (16, 17) . A high incidence of GD has previously been demonstrated in the young in an area with high iodine intake and it has also been shown that when increasing the iodization of salt, hyperthyroidism increased in young subjects where GD is expected to predominate (12, 18) . In our study, we do not have data on the actual iodine status, but Sweden is assumed to be iodine sufficient because the salt has been iodized since 1936, with an increase of added iodine from 1966. We do not have knowledge of the actual iodine status in the population of immigrants but a substantial proportion of the immigrants may come from areas with iodine deficiency. This can be one factor that may contribute to the high share of GD found in the group of patients born outside Europe.
Genetic factors have been shown to strongly influence the development of autoimmune thyroid disease in twins but the impact of specific genes is still poorly understood (19) . The most consistently found genes are HLA class II, CTLA4, PTPN22 and Thyrotropin receptor. Other genes where strong evidence is building are TG, CD40, IL2RA, and FCRL3 (20) . It is thought that the genotype of GD is polygenic and that different mixes of genes will affect the risk to develop the phenotype of Graves. One of the most consistently found genes in autoimmune thyroid disease was CTLA4 that has been found in both Caucasian and Asian subjects (21) . In our study, we do not yet have information on the genetic background of patients born in Sweden or in immigrants. Whether the difference in incidence between these groups is explained by an influx of new gene variants or a different mixture of risk genes has to be investigated in future studies.
Smoking is suggested to be a major risk factor in Graves' ophthalmopathy and a minor risk factor in GD (22, 23) . The latter fact is supported by our data because the proportion of smokers varied between the groups with different geographic origin where the lowest share of smokers was observed in the group with the highest share of GD. Therefore, factors other than smoking may contribute to GD.
Estrogen has been shown to be lower in smoking women and the use of oral contraceptives or estrogen has been associated with a lower frequency of GD (24) (25) (26) (27) .
Another observation in the present study was the large difference in age-related incidence in women 20-29 years born in Sweden or outside Sweden where the latter group exhibited a significantly higher incidence. It is well known that the postpartum period is associated with an increased frequency of GD that may influence Figure 2 Age-specific incidence of Graves' thyrotoxicosis in females born in Sweden (triangles) or outside Sweden (squares). The homogeneity P value was 0.12 when comparing rates of incidences in the two groups.
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www.eje-online.org the described difference in incidence if immigrant women had their children at a younger age as compared with Swedish women (28) . In this study, we have analyzed the age-related incidence and found the highest incidence of GD in women 50 -59 years old, an age when the majority of women are supposed to have achieved menopause. Whether the observed peak of incidence is explained by lowered levels of estrogen or a changed use of estrogen in the postmenopausal period has to be further investigated. Recently, a polymorphism in the estrogen receptor b-gene has been shown to be associated with a susceptibility to GD, however, functional studies have not been performed to test if decreased estrogen receptor responses increase the risk to develop GD (29) . In other types of autoimmune diseases like rheumatoid arthritis a significantly higher radiographic joint destruction has been shown in postmenopausal patients than in premenopausal patients (30) . Whether estrogen replacement therapy protects against rheumatoid arthritis has been under debate and the impact of estrogen replacement therapy in autoimmune thyroid disease should be further studied (31) . How about the decrease in TMNG and STA. Since 1990, the assay for TRab has become more sensitive and as a result several of the earlier TMNG/STA patients may have been re-classified as GD. Today, it is also more common to treat subclinical hyperthyroidism that preferentially may have reduced the cases with overt TMNG. In addition, the long tradition of using iodized salt may now have full effect on the reduction of nodular goiter in the Swedish population, that was observed in an incidence study of the Swedish inland (2). In the immigrant group, we preferentially found GD and only a small share of TMNG that may also affect the total number of cases especially since the immigrant group has increased more than the Swedish group. In addition, the proportion of inhabitants above 70 years old is reduced in immigrants who may in part explain the low number of cases with TMNG/STA in this group.
To conclude, the incidence of GD has increased and of TMNG/STA has decreased in Malmö since 1990, and the incidence was affected by several factors like geographic origin, age, and smoking habits. Whether the observed peak in age-related incidence of GD in women 50-59 years old is explained by menopausal changes has to be further investigated.
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